Replies to post #6967 on Halozyme Therapeutics Inc (HALO)

[maumar]

Yes, you are right. She may have left under duress but we can't be sure. It's just one more uncertainty to add to the list -- potential patent cliffs, timing of approval of new products and issuance of co-formulation patents, progress to phase 2 or phase 3 trials, potential new deals, transition to new longer IP rhuPH20, etc.